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LETTER TO THE EDITOR
Lack of association between Lewis phenotypes and 
ischemic heart disease
Ausência de associação entre fenótipos Lewis e doença isquêmica do coração
Antonio Padua MansurI, Márcia Cristina NovarettiII, Solange Desiree AvakianIII, José Antonio RamiresIV
Instituto do Coração (InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HCFMUSP)
The Copenhagen Male Study found an increased risk of ischemic heart disease in men with 
the Lewis blood group phenotype Le(a-b-).1 This phenotype has also been associated with insu-
lin-resistance syndrome, higher body mass index and hypertriglyceridemia in men but not in 
women.2 Alcohol consumption and a high level of leisure time physical activity have been found 
to be protective against ischemic heart disease in Le(a-b-) men.3,4 Two polymorphic loci, Se 
and Le, contribute to the synthesis of Lewis antigens, resulting in three phenotypes: Le(a-b-), 
Le(a-b+) and Le(a+b-). Se and Le genes have been mapped to chromosome 19, where they are 
probably distant and without linkage to one another. These genes code for different fucosyl-
transferases that determine where fucose residues are placed on the oligosaccharide epitope. 
Plasma oligosaccharides are passively adsorbed to the red blood cell membrane. Because some 
patients may be erroneous diagnosed as having phenotype Le(a-b-) from blood assays, Lewis 
antigens should be checked in saliva. These antigens may be present in the saliva of secretor 
patients (Se/Se, Se/se) with misdiagnosed blood Le(a-b-) phenotype.5 
We conducted a prospective, cross-sectional, age-adjusted study on 391 patients: 130 nor-
mal individuals and 261 non-diabetic patients with coronary artery disease (CAD), of whom 
108 had stable CAD and no previous myocardial infarction (MI) and 153 had acute MI. Con-
trol subjects were selected from a healthy population and had a normal medical history, phys-
ical examination and resting electrocardiogram (ECG). The diagnosis of acute myocardial 
infarction was made if the patient fulfilled two of the following criteria: (a) typical chest pain 
lasting more than 20 minutes; (b) ECG on enrollment showing segment ST-T changes with 
or without new Q wave in 2 or more consecutive leads of serial ECGs; and, (c) elevation of 
serum creatine kinase-MB (CKMB) levels above 20 IU/l sampled every 6 hours within 48 
hours after onset of chest pain. Clinical features, risk factors and lipid profiles were analyzed. 
Lewis phenotypes were evaluated in blood and saliva using the hemagglutination technique 
with monoclonal Lewis a and b antibodies. The Ethics Committee of Instituto do Coração 
(InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HCF-
MUSP), approved the study protocol. 
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Table 1. Prevalence of Lewis phenotypes among normal Brazilians, those with stable 
coronary artery disease (CAD), and those with acute myocardial infarction (MI)
Normal
(n = 130)
Stable CAD
(n = 108)
Acute MI
(n = 153)
Serum assay
Le(a-b-) 32 (24.6%) 19 (17.6%) 43 (28.1%)
Le(a-b+) 71 (54.6%) 71 (65.7%) 78 (51.0%)
Le(a+b-) 27 (20.8%) 18 (16.7%) 32 (20.9%)
Saliva assay
Non-secretor 32 (24.6%) 19 (17.6%) 39 (25.5%)
Lea 27 (20.8%) 18 (16.7%) 30 (19.6%)
Leb 48 (36.9%) 47 (43.5%) 58 (37.9%)
Lea, Leb 23 (17.7%) 24 (22.2%) 26 (17.0%)
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As shown in Table 1, the prevalence of the various Lewis phe-
notypes in blood and saliva was not associated with any clini-
cal condition. Our data suggest that in this Brazilian population, 
blood and salivary Le(a-b-) phenotype was not associated with 
CAD, acute MI, or even lipid profile. Our results are consistent 
with the recent study by Cakir et al., who were unable to show any 
association between the Le(a-b-) phenotype and coronary artery 
disease.6 They also did not find any association between the Le(a-
b-) phenotype and subclinical atherosclerosis. In their case-con-
trol study, they showed that the distribution of Lewis genotypes 
and haplotypes was the same between individuals with carotid 
intima-media thickness (IMT) > 1.0 mm and their controls. Nev-
ertheless, studies have shown that the Le(a-b-) phenotype is asso-
ciated both with hypertriglyceridemia and with increased serum 
levels of factor VIII and von Willebrand factor. Cakir et al.6 stated 
that these associations could favor future atherothrombotic dis-
ease. Future studies will be needed in order to establish what 
influence Lewis phenotypes have on Brazilian populations.
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